Your search returned 22 studies. (Get alerts for new studies):
- A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Conditions: Ovarian Cancer - Non Small Cell Lung Cancer - Prostate Cancer - Colorectal Cancer - Gastric Cancer - Esophageal Cancer - Cancer of Head and Neck
23 Locations available
- A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver
Conditions: Colorectal Neoplasms - Liver Neoplasms
3 Locations available
- Recombinant Vaccinia Virus Administered Intravenously Followed by Intratumoral Boosts in Patients With Metastatic, Refractory Colorectal Carcinoma
Conditions: Colorectal Carcinoma - CRC
1 Location available
- Safety Study of Modified Vaccinia Virus to Cancer
Conditions: Melanoma - Breast Cancer - Head and Neck Squamous Cell Cancer - Liver Cancer - Colorectal Cancer - Pancreatic Adenocarcinoma
1 Location available
- Trial of Second Generation Designer T Cells in Colorectal Carcinoma
Conditions: Colorectal Cancer
1 Location available
- MK-2206 and AZD6244 in Patients With Advanced Colorectal Carcinoma
Conditions: Colorectal Neoplasms
1 Location available
- Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer
Conditions: Mucinous Adenocarcinoma of the Colon - Mucinous Adenocarcinoma of the Rectum - Signet Ring Adenocarcinoma of the Colon - Signet Ring Adenocarcinoma of the Rectum - Stage I Colon Cancer - Stage I Rectal Cancer
1 Location available
- FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer
Conditions: Colorectal Cancer - Colorectal Carcinoma - Liver Metastases
34 Locations available
- RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma
Conditions: Colorectal Cancer
2 Locations available
- Systems Intervention to Promote Colorectal Cancer (CRC) Screening
Conditions: Carcinoma
1 Location available
- Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF
Conditions: Colorectal Cancer - Colorectal Adenocarcinoma
1 Location available
- Association Between Hepatitis C Infection and Renal Cell Carcinoma
Conditions: Hepatitis C - Renal Cell Carcinoma - Colorectal Cancer
1 Location available
- Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
Conditions: Colorectal Cancer
30 Locations available
- FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer
Conditions: Rectal Cancer - Colon Cancer - Metastasis - Adenocarcinoma
1 Location available
- Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
Conditions: Recurrent Colon Cancer - Recurrent Rectal Cancer - Stage IV Colon Cancer - Stage IV Rectal Cancer - Adenocarcinoma of the Colon - Adenocarcinoma of the Rectum - KRAS Protein, Human
1 Location available
- Randomized Phase II Adjuvant Chemotherapy ± FANG™ in Colorectal Carcinoma With Liver Metastases
Conditions: Colon Cancer
1 Location available
- Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer
Conditions: Colorectal Neoplasms - Colorectal Cancer - Colorectal Tumor - COlorectal Carcinoma
1 Location available
- A Phase II Study Using Short-Term Cultured, CD8+-Enriched Autologous Tumor-infiltrating Lymphocytes Following a Lymphocyte Depleting Regimen in Metast
Conditions: Metastatic Colorectal Cancer - Metastatic Gastric Cancer - Metastatic Pancreatic Cancer - Metastatic Hepatocellular Carcinoma - Metastatic Cholangiocarcinoma
1 Location available
- Phase 1 and 2 Study of PX-866 and Cetuximab
Conditions: Incurable Metastatic Colorectal Carcinoma - Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
31 Locations available
- Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases
Conditions: Colorectal Neoplasms - Neuroendocrine Tumors - Cholangiocarcinoma - Melanoma - Breast Cancer
1 Location available
- Safety Study of MGA271 in Refractory Cancer
Conditions: Prostate Cancer - Pancreatic Cancer - Melanoma - Renal Cell Carcinoma - Ovarian Cancer - Colorectal Cancer - Gastric Cancer - Bladder Cancer - Non-small Cell Lung Cancer - Glioblastoma
3 Locations available
- BKM120 in Cancers With PIK3CA Activating Mutations
Conditions: Lung Cancer - Breast Cancer - Colorectal Cancer - Cholangiocarcinoma - Solid Tumors
1 Location available
|